Cargando…
Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels
INTRODUCTION AND OBJECTIVE: Despite the improvements in management and treatment of chordomas over time, the risk of disease recurrence remains high. Consequently, there is a push to develop effective systemic therapeutics for newly diagnosed and recurrent disease. In order to tailor treatment for i...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557284/ https://www.ncbi.nlm.nih.gov/pubmed/36248987 http://dx.doi.org/10.3389/fonc.2022.997506 |